Wendell David Associates Inc. Reduces Position in Roche Holding AG (OTCMKTS:RHHBY)

Wendell David Associates Inc. lowered its position in shares of Roche Holding AG (OTCMKTS:RHHBY) by 4.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 12,100 shares of the company’s stock after selling 600 shares during the quarter. Wendell David Associates Inc.’s holdings in Roche were worth $422,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the company. Bard Financial Services Inc. lifted its holdings in Roche by 37.7% in the fourth quarter. Bard Financial Services Inc. now owns 110,850 shares of the company’s stock valued at $3,866,000 after acquiring an additional 30,350 shares during the period. GAMMA Investing LLC boosted its holdings in Roche by 57.7% during the third quarter. GAMMA Investing LLC now owns 7,944 shares of the company’s stock worth $317,000 after buying an additional 2,906 shares in the last quarter. Diversified Trust Co increased its holdings in Roche by 6.4% in the third quarter. Diversified Trust Co now owns 59,742 shares of the company’s stock valued at $2,396,000 after buying an additional 3,613 shares in the last quarter. Norman Fields Gottscho Capital Management LLC raised its position in shares of Roche by 5.5% in the third quarter. Norman Fields Gottscho Capital Management LLC now owns 26,000 shares of the company’s stock worth $1,039,000 after acquiring an additional 1,350 shares during the period. Finally, Canopy Partners LLC boosted its stake in shares of Roche by 4.6% during the 3rd quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock worth $310,000 after acquiring an additional 344 shares in the last quarter.

Roche Stock Performance

OTCMKTS RHHBY opened at $37.85 on Thursday. The stock has a 50-day moving average of $35.74 and a 200 day moving average of $38.10. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.86. Roche Holding AG has a twelve month low of $29.20 and a twelve month high of $42.43.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.